ANGPT2 and colorectal carcinoma: The colorectal carcinoma xenograft model used in this study offers an ideal model to investigate the mechanisms responsible for resistance to anti-angiogenic therapy mediated by co-targeting VEGF and Ang-2 since some tumors will start growing under therapy in a reliable manner and the onset can be monitored easily, respectively.